Regeneron Pharmaceuticals Stock Forward View - Simple Exponential Smoothing
| REGN Stock | USD 803.17 19.52 2.49% |
Regeneron Stock outlook is based on your current time horizon. Although Regeneron Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Regeneron Pharmaceuticals' systematic risk associated with finding meaningful patterns of Regeneron Pharmaceuticals fundamentals over time.
As of today the rsi of Regeneron Pharmaceuticals' share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Earnings Growth (0.03) | EPS Estimate Next Quarter 9.76 | EPS Estimate Current Year 44.6968 | EPS Estimate Next Year 47.0085 | Wall Street Target Price 868.0385 |
Using Regeneron Pharmaceuticals hype-based prediction, you can estimate the value of Regeneron Pharmaceuticals from the perspective of Regeneron Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Regeneron Pharmaceuticals using Regeneron Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Regeneron using crowd psychology based on the activity and movement of Regeneron Pharmaceuticals' stock price.
Regeneron Pharmaceuticals Short Interest
An investor who is long Regeneron Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Regeneron Pharmaceuticals and may potentially protect profits, hedge Regeneron Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 627.1024 | Short Percent 0.0217 | Short Ratio 2.49 | Shares Short Prior Month 2.3 M | 50 Day MA 758.623 |
Regeneron Relative Strength Index
The Simple Exponential Smoothing forecasted value of Regeneron Pharmaceuticals on the next trading day is expected to be 803.17 with a mean absolute deviation of 11.57 and the sum of the absolute errors of 694.36.Regeneron Pharmaceuticals Hype to Price Pattern
Investor biases related to Regeneron Pharmaceuticals' public news can be used to forecast risks associated with an investment in Regeneron. The trend in average sentiment can be used to explain how an investor holding Regeneron can time the market purely based on public headlines and social activities around Regeneron Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Regeneron Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals Implied Volatility | 0.45 |
Regeneron Pharmaceuticals' implied volatility exposes the market's sentiment of Regeneron Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Regeneron Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Regeneron Pharmaceuticals stock will not fluctuate a lot when Regeneron Pharmaceuticals' options are near their expiration.
The Simple Exponential Smoothing forecasted value of Regeneron Pharmaceuticals on the next trading day is expected to be 803.17 with a mean absolute deviation of 11.57 and the sum of the absolute errors of 694.36. Regeneron Pharmaceuticals after-hype prediction price | USD 806.82 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Regeneron | Build AI portfolio with Regeneron Stock |
Prediction based on Rule 16 of the current Regeneron contract
Based on the Rule 16, the options market is currently suggesting that Regeneron Pharmaceuticals will have an average daily up or down price movement of about 0.0281% per day over the life of the 2026-05-15 option contract. With Regeneron Pharmaceuticals trading at USD 803.17, that is roughly USD 0.23 . If you think that the market is fully incorporating Regeneron Pharmaceuticals' daily price movement you should consider acquiring Regeneron Pharmaceuticals options at the current volatility level of 0.45%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-05-15 Regeneron Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Regeneron Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Regeneron Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Regeneron Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Regeneron Pharmaceuticals' open interest, investors have to compare it to Regeneron Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Regeneron Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Regeneron. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Regeneron Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Regeneron price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Regeneron using various technical indicators. When you analyze Regeneron charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Regeneron Pharmaceuticals Simple Exponential Smoothing Price Forecast For the 16th of February 2026
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Regeneron Pharmaceuticals on the next trading day is expected to be 803.17 with a mean absolute deviation of 11.57, mean absolute percentage error of 220.90, and the sum of the absolute errors of 694.36.Please note that although there have been many attempts to predict Regeneron Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Regeneron Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Regeneron Pharmaceuticals Stock Forecast Pattern
| Backtest Regeneron Pharmaceuticals | Regeneron Pharmaceuticals Price Prediction | Research Analysis |
Regeneron Pharmaceuticals Forecasted Value
In the context of forecasting Regeneron Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Regeneron Pharmaceuticals' downside and upside margins for the forecasting period are 801.18 and 805.16, respectively. We have considered Regeneron Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Regeneron Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Regeneron Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 121.6703 |
| Bias | Arithmetic mean of the errors | -1.3123 |
| MAD | Mean absolute deviation | 11.5727 |
| MAPE | Mean absolute percentage error | 0.0153 |
| SAE | Sum of the absolute errors | 694.36 |
Predictive Modules for Regeneron Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Regeneron Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Regeneron Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Regeneron Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Regeneron Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Regeneron Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Regeneron Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Regeneron Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Regeneron Pharmaceuticals' historical news coverage. Regeneron Pharmaceuticals' after-hype downside and upside margins for the prediction period are 722.85 and 808.81, respectively. We have considered Regeneron Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Regeneron Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Regeneron Pharmaceuticals is based on 3 months time horizon.
Regeneron Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Regeneron Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Regeneron Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Regeneron Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.23 | 1.99 | 3.65 | 0.82 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
803.17 | 806.82 | 0.45 |
|
Regeneron Pharmaceuticals Hype Timeline
Regeneron Pharmaceuticals is at this time traded for 803.17. The entity has historical hype elasticity of 3.65, and average elasticity to hype of competition of -0.82. Regeneron is forecasted to increase in value after the next headline, with the price projected to jump to 806.82 or above. The average volatility of media hype impact on the company the price is about 12.53%. The price boost on the next news is projected to be 0.45%, whereas the daily expected return is at this time at 0.23%. The volatility of related hype on Regeneron Pharmaceuticals is about 56.07%, with the expected price after the next announcement by competition of 802.35. The company reported the previous year's revenue of 14.34 B. Net Income was 4.5 B with profit before overhead, payroll, taxes, and interest of 6.39 B. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Historical Fundamental Analysis of Regeneron Pharmaceuticals to cross-verify your projections.Regeneron Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Regeneron Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Regeneron Pharmaceuticals' future price movements. Getting to know how Regeneron Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Regeneron Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CI | Cigna Corp | 7.33 | 8 per month | 1.15 | 0.08 | 3.15 | (2.24) | 7.49 | |
| ELV | Elevance Health | 0.72 | 11 per month | 2.79 | 0.07 | 3.78 | (2.51) | 19.95 | |
| ALNY | Alnylam Pharmaceuticals | (18.38) | 10 per month | 0.00 | (0.24) | 2.79 | (5.47) | 10.84 | |
| ZTS | Zoetis Inc | (0.57) | 10 per month | 1.11 | 0.02 | 2.74 | (2.21) | 8.16 | |
| COR | Cencora | (15.00) | 8 per month | 2.33 | (0.03) | 2.01 | (2.62) | 10.81 | |
| ARGX | argenx NV ADR | (13.21) | 9 per month | 0.00 | (0.09) | 2.29 | (3.07) | 7.34 | |
| GMAB | Genmab AS | 1.16 | 11 per month | 2.17 | 0 | 4.09 | (3.42) | 9.44 | |
| IDXX | IDEXX Laboratories | 4.81 | 9 per month | 0.00 | (0.13) | 3.61 | (3.18) | 10.16 | |
| INCY | Incyte | 4.64 | 10 per month | 0.00 | (0.05) | 4.10 | (3.38) | 13.76 | |
| UTHR | United Therapeutics | (6.99) | 10 per month | 1.16 | 0 | 1.94 | (1.99) | 5.21 |
Other Forecasting Options for Regeneron Pharmaceuticals
For every potential investor in Regeneron, whether a beginner or expert, Regeneron Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Regeneron Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Regeneron. Basic forecasting techniques help filter out the noise by identifying Regeneron Pharmaceuticals' price trends.Regeneron Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Regeneron Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Regeneron Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Regeneron Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Regeneron Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Regeneron Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regeneron Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Regeneron Pharmaceuticals stock market strength indicators, traders can identify Regeneron Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0263 | |||
| Daily Balance Of Power | 0.9216 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 795.59 | |||
| Day Typical Price | 798.12 | |||
| Market Facilitation Index | 21.18 | |||
| Price Action Indicator | 17.34 | |||
| Period Momentum Indicator | 19.52 |
Regeneron Pharmaceuticals Risk Indicators
The analysis of Regeneron Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Regeneron Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting regeneron stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.58 | |||
| Semi Deviation | 1.45 | |||
| Standard Deviation | 1.98 | |||
| Variance | 3.92 | |||
| Downside Variance | 2.68 | |||
| Semi Variance | 2.11 | |||
| Expected Short fall | (1.95) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Regeneron Pharmaceuticals
The number of cover stories for Regeneron Pharmaceuticals depends on current market conditions and Regeneron Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Regeneron Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Regeneron Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Regeneron Pharmaceuticals Short Properties
Regeneron Pharmaceuticals' future price predictability will typically decrease when Regeneron Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Regeneron Pharmaceuticals often depends not only on the future outlook of the potential Regeneron Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regeneron Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 108.6 M | |
| Cash And Short Term Investments | 8.6 B |
Check out Historical Fundamental Analysis of Regeneron Pharmaceuticals to cross-verify your projections. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Will Biotechnology sector continue expanding? Could Regeneron diversify its offerings? Factors like these will boost the valuation of Regeneron Pharmaceuticals. Anticipated expansion of Regeneron directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Regeneron Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.03) | Dividend Share 3.52 | Earnings Share 41.44 | Revenue Per Share | Quarterly Revenue Growth 0.025 |
Investors evaluate Regeneron Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Regeneron Pharmaceuticals' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Regeneron Pharmaceuticals' market price to deviate significantly from intrinsic value.
It's important to distinguish between Regeneron Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Regeneron Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Regeneron Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.